Assoc. Prof. MD. Sema Türker

Education and Specialization

• 1998–2004 Ankara University Faculty of Medicine

• 2004–2010 Akdeniz University Faculty of Medicine, Department of Internal Medicine

• 2016–2019 Ankara Dışkapı Yıldırım Beyazıt Training and Research Hospital, Department of Medical Oncology

Experience

• 2010–2011 Polatlı Duatepe State Hospital, Internal Medicine Specialist

• 2011–2016 Marmaris State Hospital, Internal Medicine Specialist

• 2014–2015 Gölcük Necati Çelik State Hospital, Internal Medicine Specialist

• 2016 Ankara Training and Research Hospital, Internal Medicine Specialist

• 2016–2019 Ankara Dışkapı Yıldırım Beyazıt Training and Research Hospital, Medical Oncology Fellow

• 2019–2021 Zonguldak Bülent Ecevit University, Medical Oncology Specialist

• 2019–2021 Zonguldak Atatürk State Hospital, Medical Oncology Specialist

Courses and Certifications

• TTOD Medical Oncology Proficiency Certificate

• TİHUD Internal Medicine Proficiency Certificate

• MedicReS Good Reviewer Certificate

• MedicReS Good Medical Researcher Certificate

Professional Memberships

• Turkish Society of Medical Oncology (TTOD)

• American Society of Clinical Oncology (ASCO)

• Turkish Society of Internal Medicine Specialists (TİHUD)

• Turkish Medical Association

International Peer-Reviewed Journal Articles

• Türker Sema, Çılbır E, Yilmaz KB, Yetişgin E, İmamoğlu G, İnan K, Şahinli H, Altınbaş M. “Tumor-to-tumor metastasis: Breast cancer metastasis to lung cancer” Breast J. 2020 Mar; 26(3):534-535. doi: 10.1111/tbj.13558. Epub 2019 Sep 29. PMID: 31565825.
• Türker Sema, Cilbir E, Karacin C, Altinbas M. “Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment” J Cancer Res Ther. 2020 Apr-Jun;16(3):690-692. doi: 10.4103/jcrt.JCRT_343_17. PMID: 32719294.
• Türker Sema, Cilbir E, Guven DC, Karacin C, Yalcin S. “The relation between inflammation-based parameters and survival in metastatic pancreatic cancer” J Cancer Res Ther. 2021 Apr-Jun;17(2):510-515. doi: 10.4103/jcrt.JCRT_773_19. PMID: 34121700.
• Türker, Sema, Cilbir, E., Güven, D. C., Sahinli, H., Karaçin, C., & Yalçin, S. (2021). “The Prognostic Role of AB0 Blood Groups In Pancreas Cancer” Eastern Journal of Medicine, 26(2), 224-227.
• Türker, Sema, Karaçin, C., İmamoğlu, G. İ., Eren, T., Esen, R., Çılbır, E., ... & Yazılıtaş, D. (2018). “Kolon kanserinde lokalizasyon ile nötrofil lenfosit oranı arasındaki ilişki” Ortadoğu Tıp Dergisi, 10(1), 64-67.
• Turker, Sema, Sahinli, H., Perkin, P., Yazilitas, D., Koklu, N. O., Imamoglu, G. I., ... & Altinbas, M. (2018).“Squamos cell lung cancer" case applying with dyspepsia complaints” Journal of Oncological Sciences, 4(3), 147-148.
• Karacin C, Türker Sema, Eren T, Imamoglu GI, Yılmaz K, Coskun Y, Gunes SO, Sökmen F, Yazilitas D, Şimşek Z, Altınbaş M. Predictors of Neoplasia in Colonic Wall Thickening Detected via Computerized Tomography. Cureus. 2020 Sep 20;12(9):e10553. doi: 10.7759/cureus.10553. PMID: 32968607; PMCID: PMC7505674.
• Sahinli H, Türker Sema, “The hematologic inflammatory index is a new prognostic marker in patients resected for gastric cancer” J Cancer Res Ther. 2020 Dec;16(Supplement):S144-S149. doi: 10.4103/jcrt.JCRT_560_19. PMID: 33380669.
• Erin N, Türker Sema, Elpek Ö, Yildirim B. “ADAM proteases involved in inflammation are differentially altered in patients with gastritis or ulcer”Exp Ther Med. 2018 Feb;15(2):1999-2005. doi: 10.3892/etm.2017.5619. Epub 2017 Dec 12. PMID: 29434796; PMCID: PMC5776559.
• Erin N, Türker Sema, Elpek O, Yıldırım B. “Differential changes in Substance P, VIP as well as neprilysin levels in patients with gastritis or ulcer”Peptides. 2012 Jun;35(2):218-24. doi: 10.1016/j.peptides.2012.03.018. Epub 2012 Mar 29. PMID: 22484287.
• Coban E, Küçüktağ Sema, Basyigit S.“Platelet activation in subjects with impaired glucose tolerance. Platelets” 2007 Dec;18(8):591-4. doi: 10.1080/09537100701609019. PMID: 18041650.
• Yazisiz V, Arslan G, Ozbudak IH, Türker Sema, Erbasan F, Avci AB, Ozbudak O, Terzioglu E. “Lung involvement in patients with primary Sjögren's syndrome: what are the predictors?”Rheumatol Int. 2010 Aug;30(10):1317-24. doi: 10.1007/s00296-009-1152-8. Epub 2009 Oct 21. PMID: 19844720.